Report Summary
Eternity Insights has published a new study on Global Tuberculosis Drugs Market focusing on key segments as by Type (First-line Anti-TB Drugs,Second-line Anti-TB Drugs, Other), by Application (New Patients,Drug Resistant TB Patients, Other), and by region. This deep dive re-search report highlights the market and competitive intelligence across the key segments of the mar-ket. The report also considers the impact of COVID-19 on the global Tuberculosis Drugs Market.
The report considers 2018-2020 as historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the market drivers, challenges, and trends to accurately map the market scenario and competition. Moreover, key insights related to market having direct impact on the market will also be covered.
Tuberculosis Drugs Market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
Global Tuberculosis Drugs Market Size, 2018-2028 (USD Million)
To learn more about this report
Global Tuberculosis Drugs Market Segmentation:
Tuberculosis Drugs Market, By Type
- First-line Anti-TB Drugs
- Second-line Anti-TB Drugs
- Other
Tuberculosis Drugs Market, By Application
- New Patients
- Drug Resistant TB Patients
- Other
To learn more about this report
Geographically, the market is categorized in to five regions as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America region dominates the global Tuberculosis Drugs market in terms of demand generation. The Tuberculosis Drugs market in Asia Pacific region is expected to grow at significantly high growth rate. The regional market is further sub-segmented and analyzed at granular level across key countries. The report will include market size and forecast for Tuberculosis Drugs market for below listed coun-tries across each region.
North America (U.S. and Canada), Europe (Germany, France, Italy, UK, Spain, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific region); Latin America (Brazil, Mexico, and rest of the Latin America); Middle East and Africa (GCC, South Africa, and Rest of the Middle East and Africa).
Global Tuberculosis Drugs Market Taxonomy:
To learn more about this report
Global Tuberculosis Drugs Market Competitive Landscape
The global Tuberculosis Drugs market analysis report covers detailed analysis of competitive scenario across globe. The report includes profiles of leading players covering below details
- Company Overview
- Financial Analysis
- Product Portfolio Analysis
- Strategic Overview
- SWOT Analysis
List of Companies Profiled in the report:
- Sanofi
- Pfizer
- Janssen Products
- Otsuka
- AstraZeneca
- Lupin Pharmaceuticals
- Akorn
- STI Pharma
- Sandoz
- Labatec Pharma SA
- Archivel Farma
- BioMerieux
- Cepheid
- Epistem
- Other Players of Specific Interest can be added based on requirement
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
First-line Anti-TB Drugs,Second-line Anti-TB Drugs, Other |
| By Application Outlook |
New Patients,Drug Resistant TB Patients, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Sanofi,Pfizer,Janssen Products,Otsuka,AstraZeneca,Lupin Pharmaceuticals,Akorn,STI Pharma,Sandoz,Labatec Pharma SA,Archivel Farma,BioMerieux,Cepheid,Epistem |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Benefits to the stake holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes an in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Table Of Contents
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Tuberculosis Drugs Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Tuberculosis Drugs Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Tuberculosis Drugs Market Performance
2.3 USA Tuberculosis Drugs Market Performance
2.4 Europe Tuberculosis Drugs Market Performance
2.5 Japan Tuberculosis Drugs Market Performance
2.6 Korea Tuberculosis Drugs Market Performance
2.7 India Tuberculosis Drugs Market Performance
2.8 Southeast Asia Tuberculosis Drugs Market Performance
2.9 South America Tuberculosis Drugs Market Performance
3 Global Tuberculosis Drugs Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Tuberculosis Drugs Market Performance (Volume)
3.3 USA Tuberculosis Drugs Market Performance (Volume)
3.4 Europe Tuberculosis Drugs Market Performance (Volume)
3.5 Japan Tuberculosis Drugs Market Performance (Volume)
3.6 Korea Tuberculosis Drugs Market Performance (Volume)
3.7 India Tuberculosis Drugs Market Performance (Volume)
3.8 Southeast Asia Tuberculosis Drugs Market Performance (Volume)
3.9 South America Tuberculosis Drugs Market Performance (Volume)
4 Competitive Analysis
4.1 Sanofi
4.1.1 Sanofi Profiles
4.1.2 Sanofi Product Information
4.1.3 Sanofi Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.1.4 Sanofi Tuberculosis Drugs Business Performance
4.1.5 SWOT Analysis
4.2 Pfizer
4.2.1 Pfizer Profiles
4.2.2 Pfizer Product Information
4.2.3 Pfizer Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.2.4 Pfizer Tuberculosis Drugs Business Performance
4.2.5 SWOT Analysis
4.3 Janssen Products
4.3.1 Janssen Products Profiles
4.3.2 Janssen Products Product Information
4.3.3 Janssen Products Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.3.4 Janssen Products Tuberculosis Drugs Business Performance
4.3.5 SWOT Analysis
4.4 Otsuka
4.4.1 Otsuka Profiles
4.4.2 Otsuka Product Information
4.4.3 Otsuka Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.4.4 Otsuka Tuberculosis Drugs Business Performance
4.4.5 SWOT Analysis
4.5 AstraZeneca
4.5.1 AstraZeneca Profiles
4.5.2 AstraZeneca Product Information
4.5.3 AstraZeneca Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.5.4 AstraZeneca Tuberculosis Drugs Business Performance
4.5.5 SWOT Analysis
4.6 Lupin Pharmaceuticals
4.6.1 Lupin Pharmaceuticals Profiles
4.6.2 Lupin Pharmaceuticals Product Information
4.6.3 Lupin Pharmaceuticals Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.6.4 Lupin Pharmaceuticals Tuberculosis Drugs Business Performance
4.6.5 SWOT Analysis
4.7 Akorn
4.7.1 Akorn Profiles
4.7.2 Akorn Product Information
4.7.3 Akorn Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.7.4 Akorn Tuberculosis Drugs Business Performance
4.7.5 SWOT Analysis
4.8 STI Pharma
4.8.1 STI Pharma Profiles
4.8.2 STI Pharma Product Information
4.8.3 STI Pharma Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.8.4 STI Pharma Tuberculosis Drugs Business Performance
4.8.5 SWOT Analysis
4.9 Sandoz
4.9.1 Sandoz Profiles
4.9.2 Sandoz Product Information
4.9.3 Sandoz Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.9.4 Sandoz Tuberculosis Drugs Business Performance
4.9.5 SWOT Analysis
4.10 Labatec Pharma SA
4.10.1 Labatec Pharma SA Profiles
4.10.2 Labatec Pharma SA Product Information
4.10.3 Labatec Pharma SA Tuberculosis Drugs Production, Revenue, Price and Gross Margin
4.10.4 Labatec Pharma SA Tuberculosis Drugs Business Performance
4.10.5 SWOT Analysis
4.11 Archivel Farma
4.12 BioMerieux
4.13 Cepheid
4.14 Epistem
5 Competitive Landscape
5.1 Global Tuberculosis Drugs Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Tuberculosis Drugs Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Tuberculosis Drugs Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Tuberculosis Drugs Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Tuberculosis Drugs Market Assessment by Regions
6.1 Global Tuberculosis Drugs Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Tuberculosis Drugs Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Tuberculosis Drugs Price (USD/Unit) by Regions (2014-2020)
6.4 Global Tuberculosis Drugs Gross Margin by Regions (2014-2020)
7 Tuberculosis Drugs Regional Analysis
7.1 China Tuberculosis Drugs Production, Revenue and Growth Rate (2014-2020)
7.2 USA Tuberculosis Drugs Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Tuberculosis Drugs Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Tuberculosis Drugs Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Tuberculosis Drugs Production, Revenue and Growth Rate (2014-2020)
7.6 India Tuberculosis Drugs Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Tuberculosis Drugs Production, Revenue and Growth Rate (2014-2020)
7.8 South America Tuberculosis Drugs Production, Revenue and Growth Rate (2014-2020)
8 Global Tuberculosis Drugs Consumption Assessment
8.1 Global Tuberculosis Drugs Consumption and Market Share by Regions (2014-2020)
8.2 Global Tuberculosis Drugs Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Tuberculosis Drugs Average Price (USD/Unit) by Regions (2014-2020)
9 Global Tuberculosis Drugs Sales Assessment by Regions
9.1 Global Tuberculosis Drugs Sales and Sales Value (2014-2020)
9.2 China Tuberculosis Drugs Sales and Sales Value (2014-2020)
9.3 USA Tuberculosis Drugs Sales and Sales Value (2014-2020)
9.4 Europe Tuberculosis Drugs Sales and Sales Value (2014-2020)
9.5 Japan Tuberculosis Drugs Sales and Sales Value (2014-2020)
9.6 Korea Tuberculosis Drugs Sales and Sales Value (2014-2020)
9.7 India Tuberculosis Drugs Sales and Sales Value (2014-2020)
9.8 Southeast Asia Tuberculosis Drugs Sales and Sales Value (2014-2020)
9.9 South America Tuberculosis Drugs Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2020-2026
12.1 Production and Revenue Forecast 2020-2026
12.1.1 Global Tuberculosis Drugs Production and Revenue by Regions 2020-2026
12.1.2 China Tuberculosis Drugs Production, Revenue and Growth Rate 2020-2026
12.1.3 USA Tuberculosis Drugs Production, Revenue and Growth Rate 2020-2026
12.1.4 Europe Tuberculosis Drugs Production, Revenue and Growth Rate 2020-2026
12.1.5 Japan Tuberculosis Drugs Production, Revenue and Growth Rate 2020-2026
12.1.6 Korea Tuberculosis Drugs Production, Revenue and Growth Rate 2020-2026
12.1.7 India Tuberculosis Drugs Production, Revenue and Growth Rate 2020-2026
12.1.8 Southeast Asia Tuberculosis Drugs Production, Revenue and Growth Rate 2020-2026
12.1.9 South America Tuberculosis Drugs Production, Revenue and Growth Rate 2020-2026
12.2 Sales and Sales Value Forecast 2020-2026
12.2.1 Global Tuberculosis Drugs Consumption and Consumption Calue by Regions 2020-2026
12.2.2 Global Tuberculosis Drugs Sales and Sales Value Forecast 2020-2026
12.2.3 China Tuberculosis Drugs Sales, Sales Value and Growth Rate 2020-2026
12.2.4 USA Tuberculosis Drugs Sales and Sales Value Forecast 2020-2026
12.2.5 Europe Tuberculosis Drugs Sales and Sales Value Forecast 2020-2026
12.2.6 Japan Tuberculosis Drugs Sales and Sales Value Forecast 2020-2026
12.2.7 Korea Tuberculosis Drugs Sales and Sales Value Forecast 2020-2026
12.2.8 India Tuberculosis Drugs Sales and Sales Value Forecast 2020-2026
12.2.9 Southeast Asia Tuberculosis Drugs Sales and Sales Value Forecast 2020-2026
12.2.10 South America Tuberculosis Drugs Sales and Sales Value Forecast 2020-2026
12.3 Global Tuberculosis Drugs Production and Revenue Forecast by Type 2020-2026
12.3.1 Overall Market Performance
12.3.2 First-line Anti-TB Drugs
12.3.3 Second-line Anti-TB Drugs
12.4 Global Tuberculosis Drugs Sales Forecast by Application 2020-2026
12.4.1 Overall Market Performance
12.4.2 New Patients
12.4.3 Drug Resistant TB Patients
12.5 Global Tuberculosis Drugs Price and Gross Margin Forecast
13.5.1 Global Tuberculosis Drugs Averages Price Development Trend Forecast 2020-2026
13.5.2 Global Tuberculosis Drugs Gross Margin Development Trend Forecast 2020-2026
13 Conclusion
